Is your child currently experiencing Crohn’s disease flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce abdominal pain and cramps, fatigue, bloody stool, weight loss, and/or liver disease associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children 2–17 years old to join a Crohn’s disease trial to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderately to severely active IBD (including associated symptoms such as tiredness, loss of appetite, diarrhea, frequent fevers and/or anemia), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing Crohn’s disease flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal pain and cramps, stomach pain, bloody stool, frequent fevers, and/or liver disease associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children and teenagers 2–17 years of age to join a clinical trial to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or moderate to severe IBD (including associated symptoms such as rectal pain, joint pain, cramps, chronic fatigue and/or liver disease), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s and UC flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal cramps, abdominal cramps, bloody stool, chronic fatigue, and/or canker sores associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children 2 to 17 years old to join a research to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or UC (including associated symptoms such as fatigue, kidney stones, diarrhea, malnutrition and/or anemia), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing CD flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce diarrhea with blood and pus, mouth sores, abdominal pain, weight loss, and/or canker sores associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe ulcerative colitis (including associated symptoms such as swollen joints, perianal fistula, abdominal pain, chronic fatigue and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing ulcerative colitis flare-ups? Local clinical research is testing a potential new medication to see if it may reduce joint pain, fistula, cramps, frequent fevers, and/or anemia associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local CD research is testing a potential new medication to see if it may reduce urgency to defecate, stomach pain, rectal pain, frequent fevers, and/or eye pain associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.